Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 5.1% in November

Cibus, Inc. (NASDAQ:CBUS - Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 2,050,000 shares, a growth of 5.1% from the November 15th total of 1,950,000 shares. Approximately 11.0% of the company's shares are sold short. Based on an average trading volume of 204,400 shares, the short-interest ratio is currently 10.0 days.

Analysts Set New Price Targets

Several research analysts have commented on the company. Canaccord Genuity Group reaffirmed a "buy" rating and set a $20.00 target price on shares of Cibus in a report on Tuesday, October 22nd. HC Wainwright restated a "buy" rating and set a $25.00 price target on shares of Cibus in a report on Monday, November 11th. Finally, Alliance Global Partners lowered their target price on shares of Cibus from $25.00 to $23.50 and set a "buy" rating for the company in a research note on Tuesday, September 24th.

Cibus Price Performance

Shares of Cibus stock traded down $0.19 during trading on Monday, reaching $3.89. 115,227 shares of the company traded hands, compared to its average volume of 134,803. The firm has a market capitalization of $102.93 million, a PE ratio of -0.18 and a beta of 1.86. Cibus has a 1-year low of $2.86 and a 1-year high of $23.18. The company has a 50 day moving average price of $4.15 and a 200-day moving average price of $6.55.

Hedge Funds Weigh In On Cibus

Institutional investors have recently made changes to their positions in the stock. SG Americas Securities LLC acquired a new position in Cibus during the third quarter worth $33,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Cibus in the 3rd quarter worth about $44,000. Virtu Financial LLC bought a new position in Cibus in the 3rd quarter valued at about $48,000. HighTower Advisors LLC boosted its stake in Cibus by 20.6% during the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company's stock valued at $52,000 after purchasing an additional 2,750 shares during the last quarter. Finally, Barclays PLC increased its holdings in Cibus by 287.2% during the 3rd quarter. Barclays PLC now owns 20,269 shares of the company's stock worth $66,000 after purchasing an additional 15,034 shares in the last quarter. Institutional investors and hedge funds own 33.81% of the company's stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.